Clinical Trial Update: Study of PX-866 and Docetaxel in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1/2 study of PX-866 with docetaxel in solid tumors, including non-small cell lung cancer and squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PX-866 (PX-866)

Snippet

Sponsor: Cascadian Therapeutics Inc. | Conditions: Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 1, Phase 2 | Status: COMPLETED